| Application no. and date | 10180857.4 (espacenet) (Federated) (European Patent Register), 20010511 | | Patent/reg. no. and date | DK/EP 2363139, 20160302 | | Publication date | 20110907 | | Priority no. and date | US 203758 P, 20000512 | | EP pub. no. and date |
EP 2363139 20110907 | | Effective date | | | Applicant/owner | NorthWest Biotherapeutics, Inc., 4800 Montgomery Lane, Suite 800
Bethesda. MD 20814, US | | Applicant ref. no. | P81110128DK01E | | Inventor | Salgaller, Michael L., 1027 Wintergreen Terrace
Rockville, MD 20850, US,
Boynton, Alton L., P.O. Box 786
Andover, KS 67002, US | | Representative | Zacco Denmark A/S, Arne Jacobsens Allé 15, 2300 København S | | Opponent | | | IPC Class | A61K 39/00 (2006.01) | | Title | Fremgangsmåde til at øge klasse I-præsentation af eksogene antigener gennem humane dendritiske celler | | Int. application no. | | | Int. publication no. | | | Related patent (certificate) | | | Status | Bortfaldet | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
